IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

November 30, 2005

Conditions
Schizophrenia
Interventions
DRUG

Ziprasidone

Trial Locations (34)

3039

Pfizer Investigational Site, Sora

10024

Pfizer Investigational Site, Moncalieri(to)

10043

Pfizer Investigational Site, Orbassano (TO)

10126

Pfizer Investigational Site, Torino

10154

Pfizer Investigational Site, Torino

12038

Pfizer Investigational Site, Savigliano

16132

Pfizer Investigational Site, Genova

16154

Pfizer Investigational Site, Genova-sestri

20142

Pfizer Investigational Site, Milan

25032

Pfizer Investigational Site, Chiari (BS)

26100

Pfizer Investigational Site, Cremona

33100

Pfizer Investigational Site, Udine

33170

Pfizer Investigational Site, Pordenone

35128

Pfizer Investigational Site, Padua

37063

Pfizer Investigational Site, Verona

40100

Pfizer Investigational Site, Bologna

41100

Pfizer Investigational Site, Modena

43036

Pfizer Investigational Site, Fidenza(pr)

43100

Pfizer Investigational Site, Parma

50013

Pfizer Investigational Site, Campi Bisenzio

55049

Pfizer Investigational Site, Viareggio

60019

Pfizer Investigational Site, Senigallia (AN)

60020

Pfizer Investigational Site, Torrette DI Ancona (AN)

71100

Pfizer Investigational Site, Foggia

73100

Pfizer Investigational Site, Lecce

80136

Pfizer Investigational Site, Napoli

81100

Pfizer Investigational Site, Caserta

84037

Pfizer Investigational Site, S. Arsenio

90145

Pfizer Investigational Site, Palermo

96017

Pfizer Investigational Site, Noto

09100

Pfizer Investigational Site, Cagliari

06100

Pfizer Investigational Site, Perugia

00149

Pfizer Investigational Site, Roma

07100

Pfizer Investigational Site, Sassari

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00136994 - IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) | Biotech Hunter | Biotech Hunter